147 related articles for article (PubMed ID: 25343234)
1. Positive association between serum levels of bone resorption marker CTX and HbA1c in women with normal glucose tolerance.
Xuan Y; Sun LH; Liu DM; Zhao L; Tao B; Wang WQ; Zhao HY; Liu JM; Ning G
J Clin Endocrinol Metab; 2015 Jan; 100(1):274-81. PubMed ID: 25343234
[TBL] [Abstract][Full Text] [Related]
2. The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women.
Liu DM; Zhao HY; Zhao L; Zhang MJ; Liu TT; Tao B; Sun LH; Liu JM
Endocrine; 2018 Feb; 59(2):304-310. PubMed ID: 29294226
[TBL] [Abstract][Full Text] [Related]
3. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
[TBL] [Abstract][Full Text] [Related]
4. Bone turnover markers in children and adolescents with type 1 diabetes-A systematic review.
Madsen JOB; Jørgensen NR; Pociot F; Johannesen J
Pediatr Diabetes; 2019 Aug; 20(5):510-522. PubMed ID: 30941847
[TBL] [Abstract][Full Text] [Related]
5. Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women.
Liu DM; Lu N; Zhao L; Zhang MJ; Tao B; Xuan Y; Sun LH; Zhao HY; Wang WQ; Liu JM; Ning G
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2504-9. PubMed ID: 25050899
[TBL] [Abstract][Full Text] [Related]
6. Association between glycosylated hemoglobin A1c and bone biochemical markers in type 2 diabetic postmenopausal women: a cross-sectional study.
Wang L; Li T; Liu J; Wu X; Wang H; Li X; Xu E; Chen Q; Yan C; Li H; Xu Y; Wei W
BMC Endocr Disord; 2019 Mar; 19(1):31. PubMed ID: 30866902
[TBL] [Abstract][Full Text] [Related]
7. Differences in biochemical bone markers by diabetes type and the impact of glucose.
Starup-Linde J; Lykkeboe S; Gregersen S; Hauge EM; Langdahl BL; Handberg A; Vestergaard P
Bone; 2016 Feb; 83():149-155. PubMed ID: 26555635
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of circadian variation in bone resorption.
Bjarnason NH; Henriksen EE; Alexandersen P; Christgau S; Henriksen DB; Christiansen C
Bone; 2002 Jan; 30(1):307-13. PubMed ID: 11792602
[TBL] [Abstract][Full Text] [Related]
9. Decreased markers of bone turnover in children and adolescents with type 1 diabetes.
Madsen JOB; Herskin CW; Zerahn B; Jørgensen NR; Olsen BS; Pociot F; Johannesen J
Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841
[TBL] [Abstract][Full Text] [Related]
10. C-terminal telopeptide of type I collagen, osteocalcin, alkaline phosphatase, and parathyroid hormone in healthy and hospitalized foals.
Kamr AM; Dembek KA; Gilsenan W; Bozorgmanesh R; Hassan HY; Rosol TJ; Toribio RE
Domest Anim Endocrinol; 2020 Jul; 72():106470. PubMed ID: 32408050
[TBL] [Abstract][Full Text] [Related]
11. Bone biomarkers in patients with chronic traumatic spinal cord injury.
Sabour H; Norouzi Javidan A; Latifi S; Larijani B; Shidfar F; Vafa MR; Heshmat R; Emami Razavi H
Spine J; 2014 Jul; 14(7):1132-8. PubMed ID: 24139865
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals.
Zhou M; Ma X; Li H; Pan X; Tang J; Gao Y; Hou X; Lu H; Bao Y; Jia W
Eur J Endocrinol; 2009 Nov; 161(5):723-9. PubMed ID: 19671707
[TBL] [Abstract][Full Text] [Related]
13. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
14. The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years.
Liu TT; Liu DM; Xuan Y; Zhao L; Sun LH; Zhao DD; Wang XF; He Y; Guo XZ; Du R; Wang JQ; Liu JM; Zhao HY; Tao B
Bone Res; 2017; 5():17020. PubMed ID: 28698818
[TBL] [Abstract][Full Text] [Related]
15. Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps.
Zikán V; Haas T; Stepan JJ
Calcif Tissue Int; 2001 Jun; 68(6):352-7. PubMed ID: 11685423
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
[TBL] [Abstract][Full Text] [Related]
17. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.
Zhao C; Liu G; Zhang Y; Xu G; Yi X; Liang J; Yang Y; Liang J; Ma C; Ye Y; Yu M; Qu X
J Clin Lab Anal; 2020 Apr; 34(4):e23112. PubMed ID: 31733013
[TBL] [Abstract][Full Text] [Related]
18. The Relationship between Serum Osteocalcin Concentration and Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus – The Role of Osteocalcin in Energy Metabolism.
Ma XY; Chen FQ; Hong H; Lv XJ; Dong M; Wang QY
Ann Nutr Metab; 2015; 66(2-3):110-116. PubMed ID: 25721846
[TBL] [Abstract][Full Text] [Related]
19. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
[TBL] [Abstract][Full Text] [Related]
20. Age- and sex-specific association of circulating osteocalcin with dynamic measures of glucose homeostasis.
Jung KY; Kim KM; Ku EJ; Kim YJ; Lee DH; Choi SH; Jang HC; Shin CS; Park KS; Lim S
Osteoporos Int; 2016 Mar; 27(3):1021-1029. PubMed ID: 26373983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
